Abiopharma

ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry

ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry

SpringWorks Therapeutics Receives Positive CHMP Opinion for Nirogacestat for the Treatment of Adults with Desmoid Tumors

PETVIVO HOLDINGS, INC. ANNOUNCES INVESTOR EXERCISE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING

Soleno Therapeutics Announces Multiple Presentations at the 2025 United in Hope: International Prader-Willi Syndrome Conference

DARZALEX® (daratumumab) receives the first positive CHMP opinion for patients with high-risk smouldering multiple myeloma

Aptose and Hanmi Enter New Loan Agreement to Advance Development of Tuspetinib in Triplet Therapy for AML

New Form 6-K - GSK plc Filed: 2025-06-20 AccNo: 0001654954-25-007230 Size: 44 KB

New Form 6-K - Concord Medical Services Holdings Ltd Filed: 2025-06-20 AccNo: 0001104659-25-060893 Size: 11 KB

New Form 6-K - Haleon plc Filed: 2025-06-20 AccNo: 0001654954-25-007228 Size: 33 KB

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Anixa Biosciences to Host an Investor Webcast on June 26, 2025 USA - English USA - English

New Form 6-K - GSK plc Filed: 2025-06-20 AccNo: 0001654954-25-007222 Size: 1 MB

New Form S-8 - HARROW, INC. Filed: 2025-06-20 AccNo: 0001641172-25-015728 Size: 240 KB

New Form 8-K - Kalaris Therapeutics, Inc. Filed: 2025-06-20 AccNo: 0001193125-25-143202 Size: 143 KB Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 Item 8.01: Other Events